Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 107 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 12/31/24
Due: 12/31/25
Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity
Phase: N/A
Priority: Normal
Start: 10/31/19
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 09/15/18
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 05/01/18
End: 09/28/19
Due: 09/28/20
Phase: N/A
Priority: Normal
Start: 05/23/18
End: 04/23/20
Due: 04/23/21
Phase: N/A
Priority: Normal
Start: 02/01/17
End: 01/12/24
Due: 01/12/25
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/23/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 04/30/21
End: 03/15/23
Due: 03/15/24
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/30/30
Due: 12/30/31
Phase: N/A
Priority: Normal
Start: 04/20/17
End: 01/01/23
Due: 01/01/24
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 10/24/20
Due: 10/24/21
Phase: N/A
Priority: Normal
Start: 12/01/22
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 11/25/17
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 10/01/22
Due: 10/01/23
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 10/01/20
Due: 10/01/21
Phase: N/A
Priority: Normal
Start: 11/25/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 10/31/22
Due: 10/31/23